Source: Pharmabiz

Kabafusion: GC Biopharma selects KabaFusion as a distribution partner to provide Alyglo for adults with primary humoral immunodeficiency

KabaFusion, a nationally recognized leader in home infusion, has been selected by GC Biopharma USA as a limited distribution partner to provide Alyglo (Immune Globulin Intravenous, Human─stwk) 10 per cent

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Sohail Masood's photo - Chairman & CEO of Kabafusion

Chairman & CEO

Sohail Masood

CEO Approval Rating

84/100

Read more